Compare IDEXX Laboratories, Inc. (IDXX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vipshop Holdings Ltd - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $519.93 (market cap $40.43B), while Vipshop Holdings Ltd - ADR trades at $12.98 (market cap $6.05B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.7× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.87% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| IDXX | VIPS | |
|---|---|---|
Market Cap | $40.43B | $6.05B |
Volume | 692,164 | 3,719,230 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $20.29 |
52-Week Low | $504.70 | $12.09 |
Typical Hold Time | 46 Days | 49 Days |
Enterprise Value | $41.32B | $2.87B |
Dividend Yield | — | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
Vipshop Holdings (VIPS) trades at $12.98, up 1.61% with mixed technical signals showing neutral overall momentum. The stock trades at attractive valuation multiples including P/E of 4.1x and P/S of 0.4x, supported by strong profitability with 24.4% ROE. Recent earnings showed Q2 2026 miss with $0.12 EPS versus $0.59 expected, reflecting challenging retail conditions as revenue declined to $105.9B in 2025.
The investment case balances deep value metrics against growth headwinds. Analyst consensus targets $16.17 (25% upside) with 54% buy ratings, though recent earnings misses and consumer spending concerns create near-term uncertainty. The company maintains strong cash generation with $9.1B operating cash flow in 2024, supporting shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
